The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions

被引:9
作者
Avlani, Vimesh A. [1 ]
McLoughlin, David J. [2 ]
Sexton, Patrick M. [1 ]
Christopoulos, Arthur [1 ]
机构
[1] Monash Univ, Dept Pharmacol, Drug Discovery Biol Lab, Clayton, Vic 3800, Australia
[2] Pfizer Ltd, Sandwich Labs, High Throughput Screening Ctr Emphasis, Sandwich CT13 9NJ, Kent, England
关键词
D O I
10.1124/jpet.108.136978
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Radioligand binding assays remain a common method for quantifying the effects of allosteric modulators at G protein-coupled receptors. The allosteric ternary complex model (ATCM) is the simplest model applied to derive estimates of modulator affinity (K-B) and cooperativity (alpha), which are necessary for understanding structure-activity relationships. However, the increasing drive toward assay miniaturization in modern drug discovery may lead to conditions where appreciable ligand depletion occurs in the assay. Theoretical simulations investigating the impact of orthosteric radioligand depletion on the estimation of ATCM parameters revealed the following. 1) For allosteric inhibitors, application of the standard ATCM to data obtained under depletion conditions leads to an underestimation of pK(B) and an overestimation of log alpha. 2) For allosteric enhancers, the opposite was noted, but not always; the nonlinear regression algorithm is more likely to struggle to converge to a satisfactory solution of (nondepletion) ATCM parameters in this situation. 3) Application of a novel ATCM that explicitly incorporates orthosteric ligand depletion will yield more reliable model estimates, provided the degree of depletion is not high (< similar to 50%). Subsequent experiments investigated the interaction between [H-3]N-methylscopolamine and the allosteric enhancer, alcuronium, or inhibitor, gallamine, in the presence of increasing concentrations of M-2 muscarinic acetylcholine receptor and showed that application of an ATCM that explicitly incorporates radioligand depletion can indeed give more robust estimates of modulator affinity and cooperativity estimates than the standard model. These results have important implications for the quantification of allosteric modulator actions in binding-based discovery assays.
引用
收藏
页码:927 / 934
页数:8
相关论文
共 13 条
[1]   Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors [J].
Avlani, V ;
May, LT ;
Sexton, PM ;
Christopoulos, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :1062-1072
[2]   Critical role for the second extracellular loop in the binding of both orthosteric and allosteric g protein-coupled receptor Ligands [J].
Avlani, Vimesh A. ;
Gregory, Karen J. ;
Morton, Craig J. ;
Parker, Michael W. ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (35) :25677-25686
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log [J].
Christopoulos, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (09) :351-357
[5]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[6]  
CHRISTOPOULOS A, 2000, QUANTIFICATION ALLOS
[7]  
EHLERT FJ, 1988, MOL PHARMACOL, V33, P187
[8]  
LAZARENO S, 1995, MOL PHARMACOL, V48, P362
[9]   Allosteric modulation of G protein-coupled receptors [J].
May, Lauren T. ;
Leach, Katie ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 :1-51
[10]  
Motulsky H, 2004, FITTING MODELS BIOL